Dr. David Siegel featured in The Wall Street Journal

In case you missed it, two new drugs for multiple myeloma have been approved and are expected to extend life expectancy for patients with the blood cancer.

Dr. Siegel, one of the nation’s foremost authorities on multiple myeloma, shares his thoughts in an article from The Wall Street Journal.  

David S. Siegel, M.D., Ph.D., is Chief of the Myeloma Division at John Theurer Cancer Center in Hackensack, N.J.

To read the full article…

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

RELATED ARTICLES

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.